BackArriVent BioPharma Overview

ArriVent BioPharma Intangible Assets

Latest intangible assets for AVBP: $0.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$0.00

Peer average

Loading

ArriVent BioPharma Intangible Assets History

Loading

ArriVent BioPharma vs. peers: Intangible Assets Comparison

Loading

ArriVent BioPharma Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

ArriVent BioPharma (AVBP) FAQ

As of the most recent data (March 2026), AVBP shows a intangible assets of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AVBP's intangible assets is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether ArriVent BioPharma is outperforming or lagging.

Tracking AVBP's intangible assets over time shows whether ArriVent BioPharma is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has ArriVent BioPharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $0) with ownership activity and broader fundamentals.